complications of injection given in the eye for retinal diseases
Not Applicable
Completed
- Conditions
- Health Condition 1: null- healthy patients who had given intravitreal bevacizumab for ocular problem
- Registration Number
- CTRI/2015/10/006250
- Lead Sponsor
- ETHRADHAMA SUPERSPECIALITY EYE HOSPITA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
•Age > 18 years
•Any evidence of ocular neovascularisation, Choroidal neovasular membrane, macular edema due to retinal vein occlusion, diabetic retinopathy
Exclusion Criteria
•Active external eye infection like conjunctivitis, meibomitis etc.
•Ischemic maculopathy
•Presence of any active systemic infections
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study ocular complications within a year of intravitreal injection of bevacizumab. <br/ ><br>Timepoint: day1 and at 1 month <br/ ><br>
- Secondary Outcome Measures
Name Time Method nilTimepoint: nil